Skip to main content
BrainCited

항암화학요법 관련 인지 장애
Chemotherapy-Related Cognitive Impairment

유병률: Reported by 17-75% of cancer patients undergoing chemotherapy

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'condition\u003Dchemo\u002Dbrain'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    






    
    

        
        

        
        
        

            

  
About





            {# Filter order is load-bearing: escape (untrusted text) -> linebreaks
               (paragraphs) -> paper anchors (internal /papers/ links) -> glossary
               (never links inside an existing ). #}
            

                
암 화학요법과 관련된 인지 기능 장애로, 기억력, 주의력, 처리 속도에 영향을 미치며 흔히 '케모브레인'으로 불립니다. 치료 완료 후 수개월에서 수년간 지속될 수 있습니다.

            

        

        

        
        
        

            

  
Common Symptoms





            

                
                Memory difficulties
                
                Trouble concentrating
                
                Difficulty multitasking
                
                Slower processing speed
                
                Word-finding difficulty
                
            

        

        

        
        
        

            

  
Risk Factors





            
    
                
                
  • 
                    
                    Chemotherapy regimen type and duration
                
    • 
                
                
  • 
                    
                    Radiation therapy to the brain
                
    • 
                
                
  • 
                    
                    Older age at treatment
                
    • 
                
                
  • 
                    
                    Pre-existing cognitive difficulties
                
    • 
                
                
  • 
                    
                    Anemia during treatment
                
    • 
                
            

        

        

        
        
        

            

  
Frequently Asked Questions





            

                
                

                    
                        How is the evidence for 항암화학요법 관련 인지 장애 supplements graded?
                        
                    
                    

                        We grade supplements on an A-F scale based on clinical study quality, consistency of results, sample sizes, and study design. Grade A indicates strong evidence from multiple clinical trials, while Grade D indicates preliminary evidence requiring further research.
                    

                

                
                

                    
                        What are common symptoms of 항암화학요법 관련 인지 장애?
                        
                    
                    

                        Common symptoms associated with 항암화학요법 관련 인지 장애 include Memory difficulties, Trouble concentrating, Difficulty multitasking, Slower processing speed, Word-finding difficulty. If you are experiencing these symptoms, consult a healthcare professional for proper diagnosis and treatment options.
                    

                

                
            

        

        

        
        

        
        
    


    
    










    

        FDA 면책 조항:
        이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.